Roche, Zealand Pharma Obesity Drug Meets Clinical Trial’s Weight Loss Goals, But Can It Compete?

Petrelintide posted Phase 2 results showing tolerability comparable to a placebo, but average weight loss that was less than what analysts expected. The Zealand Pharma drug, in development under a partnership with Roche, is a peptide engineered to activate the amylin receptor. The post Roche, Zealand Pharma Obesity Drug Meets Clinical Trial’s Weight Loss Goals,…

Read More

Virtual-First Care Shouldn’t Spark an “A-Ha” Moment Anymore

Virtual-first done well – fully integrated with the EHR, aligned with health system clinical and quality governance, capable of warm handoffs, and simple enough that patients don’t need instructions – creates genuine surprise. That surprise is the opportunity and the problem. The post Virtual-First Care Shouldn’t Spark an “A-Ha” Moment Anymore appeared first on MedCity…

Read More

The Moment is Now: Preventive Cardiac Care is in Sight

The combination of AI and advanced signal processing, along with innovations in digital and wearable tech, places us in a moment where providers will soon be able to have high-quality data that presents the opportunity to shift from reactive heart failure treatment to preventive cardiac care.  The post The Moment is Now: Preventive Cardiac Care…

Read More

CVS, Humana & More Are Turning to Google’s AI Models

Google Cloud is partnering with healthcare organizations including CVS Health, Humana, Highmark Health, Quest Diagnostics and Waystar to deploy agentic AI tools across patient engagement, clinical workflows and revenue cycle management The post CVS, Humana & More Are Turning to Google’s AI Models appeared first on MedCity News.

Read More